Why the study?
Men and women differ in coronary artery disease presentation and management, but whether these differences translate into different clinical outcomes in stable CAD is unclear.
Do women with stable coronary artery disease have different clinical outcomes compared to men?
Population
30 977 outpatients with stable CAD
Comparison
Women vs men
Design
International prospective registry study
Follow-up
1 year
Key result
Women with stable CAD had similar 1-year rates of cardiovascular death, non-fatal MI, or stroke compared to men (adjusted rates 1.8% vs 1.7%; OR 0.93, 95% CI 0.75-1.15).
Authors
Loading...
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“For the first time, we can see that many patients with CAD have too high resting heart rate levels, and combined internal evidence from CLARIFY and external evidence from prior sources indicate that this is associated with worse symptoms and worse clinical outcomes. These findings suggest tighter control of baseline heart rate with heart-rate-lowering medications may benefit CAD patients by improving symptom control and outcomes.”
Similar 1-year outcomes in men and women with stable CAD despite management differences; challenges assumptions of inherent disparities and leaves open need for sex-specific strategies.
Cohort (n=30,977)
Yes
Do women with stable coronary artery disease have different clinical outcomes compared to men?
Odds Ratio: 0.93 (95% CI 0.75–1.15)
Absolute Event Rate: 1.8% vs 1.7%
Despite differences in risk profiles and less optimized treatment, women and men with stable coronary artery disease have similar 1-year cardiovascular outcomes, though women undergo fewer revascularizations.
Steg et al. (2012) conducted a cohort in stable coronary artery disease (n=30,977). Female sex vs. Male sex was evaluated on composite of cardiovascular death, non-fatal myocardial infarction, or stroke (OR 0.93, 95% CI 0.75-1.15). Women with stable CAD had similar 1-year rates of cardiovascular death, non-fatal MI, or stroke compared to men (adjusted rates 1.8% vs 1.7%; OR 0.93, 95% CI 0.75-1.15).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: